Power Law company profile

Pharvaris

Biotech & Life Sciences · Leiden, Netherlands · Founded 2015 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.60B

Market cap · Apr/2026

Investors

11 investors on Pharvaris's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Kurma Partners

EQT Life Sciences

Series B+ 9 investors entered at this stage

Venrock

Bain Capital

Cormorant Asset Management

Eurazeo

Foresite Capital

Bain Capital Life Sciences

Viking Global Investors

General Atlantic

venBio Partners

Global footprint

Where Pharvaris has talent and traffic

Web traffic by country

5.9K monthly visits
across markets

🇺🇸 United States64.4%

🇮🇳 India15.3%

🇨🇭 Switzerland8.5%

🇳🇱 Netherlands6.8%

🇫🇷 France3.4%

Top 5 markets shown

Patent intelligence

$15M patent portfolio · 21 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$15M

0.93% of market cap · 52.3× smaller than top peer BioNTech ($780M)

21 active patent families

Where Pharvaris innovates Bradykinin Receptor AntagonistsBradykininReceptor antagonistAcetamideBradykinin B2 Receptor Antagonists

Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Pharvaris on the five Patsnap quality dimensions

Pharvaris in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Pharvaris concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Pharvaris and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Pharvaris on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo